Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Boston Scientific
(NY:
BSX
)
90.43
-0.23 (-0.25%)
Official Closing Price
Updated: 7:00 PM EST, Dec 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Boston Scientific
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
10 Health Care Stocks With Whale Alerts In Today's Session
December 02, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
November 29, 2024
Via
Benzinga
$100 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today
November 25, 2024
Via
Benzinga
Key Takeaways From Boston Scientific Analyst Ratings
November 18, 2024
Via
Benzinga
Why Is Medical Device Giant Boston Scientific Stock Trading Higher On Monday?
November 18, 2024
Boston Scientific's latest trial shows safety and efficacy endpoints for stroke prevention in atrial fibrillation patients.
Via
Benzinga
NYSE:BSX may be ready to breakout.
November 12, 2024
Technical Setup: BOSTON SCIENTIFIC CORP Appears Poised for a Breakout.
Via
Chartmill
$1000 Invested In This Stock 15 Years Ago Would Be Worth $11,000 Today
October 29, 2024
Via
Benzinga
Behind the Scenes of Boston Scientific's Latest Options Trends
October 23, 2024
Via
Benzinga
Boston Scientific Earnings, Sales Top Q3 Views; Stock Eyes High
October 23, 2024
The medtech giant beat on the top and bottom line early Wednesday.
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
November 13, 2024
Via
Benzinga
Don’t Confuse Brains With A Bull Market, Or Price With Value
November 10, 2024
If you are interested in the stock market, maybe it is time to stop focusing on The Fed.
Via
Talk Markets
Why is Boston Scientific Stock Trading Lower On Wednesday?
October 30, 2024
Boston Scientific's ACURATE IDE trial results showed a 16.16% composite rate for mortality, stroke, or rehospitalization, not meeting non-inferiority versus controls.
Via
Benzinga
Stock Market Mixed But Nasdaq Hits Record High As Tesla Leads Earnings Winners: Weekly Review
October 25, 2024
The major indexes were mixed for the week.
Via
Investor's Business Daily
Boston Scientific's Options Frenzy: What You Need to Know
October 21, 2024
Via
Benzinga
Key Takeaways From Boston Scientific Analyst Ratings
October 14, 2024
Via
Benzinga
Performance Comparison: Boston Scientific And Competitors In Health Care Equipment & Supplies Industry
October 07, 2024
Via
Benzinga
Boston Scientific Pauses Enrollment In Farapulse Study In Drug-Naive Patients With Irregular Heart Rhythm
October 23, 2024
Boston Scientific's AVANT GUARD trial evaluates the FARAPULSE PFA System for treating persistent atrial fibrillation, pausing enrollment to assess trial observations.
Via
Benzinga
Wall Street Slumps For Third Straight Day As Investor Sentiment Fades, Dollar Strength Resumes, Boeing Disappoints: What's Driving Markets Wednesday?
October 23, 2024
Wall Street is on track for its third consecutive day of losses as investors grow cautious about risky assets, awaiting more clarity on U.S. fiscal and monetary policies and scrutinizing the latest...
Via
Benzinga
Boston Scientific Q3 Earnings: Revenue And EPS Beat, Lifts Annual Forecast On Strong Demand For Heart Devices
October 23, 2024
Boston Scientific exceeded Q3 expectations with $4.21 billion revenue and $0.63 EPS. Cardiovascular sales rose 25%, and 2024 growth guidance was updated.
Via
Benzinga
Is BOSTON SCIENTIFIC CORP Ready to Break Out of Its Range?
October 02, 2024
BOSTON SCIENTIFIC CORP (NYSE:BSX) has a good technical rating of 10 out of 10 and could possibly break out.
Via
Chartmill
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $8,100 Today
September 26, 2024
Via
Benzinga
Critical Insights From Boston Scientific Analyst Ratings: What You Need To Know
October 21, 2024
Via
Benzinga
US Hospitals Face Critical IV Fluid Shortage After Baxter Facility Shuts Down Due To Hurricane Helene
October 18, 2024
The U.S. faces a critical shortage of IV fluids due to Hurricane Helene's damage to Baxter's North Carolina plant, forcing hospitals to delay surgeries. Federal efforts to rebuild and import supplies...
Via
Benzinga
This Boston Scientific Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
October 18, 2024
Via
Benzinga
Solventum Stock Earns 81 RS Rating
October 15, 2024
Solventum stock saw a positive improvement to its Relative Strength Rating on Tuesday, with an upgrade from 78 to 81.
Via
Investor's Business Daily
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years
October 15, 2024
Via
Benzinga
18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker'
October 10, 2024
Goldman Sachs identifies 18 stocks for potential earnings upside and advises options-based strategies in a volatile market. 10% upside for S&P 500.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Boston Scientific: Why This MedTech Giant Isn’t Slowing Down
September 17, 2024
Boston Scientific Co (NYSE: BSX) is a global medical device manufacturer that’s seeing a strong influx of investors as shares grind to new all-time highs.
Via
MarketBeat
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years
September 10, 2024
Via
Benzinga
Medtronic Stock: Growth On Rise of the Cardiovascular Machines
September 09, 2024
Medtronic is a leading global medical device maker in the medical sector. Its innovative and critical medical device portfolio addresses chronic diseases
Via
MarketBeat
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.